Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Net other income and expenses outside core operations
Percentile
P100
Near historical high
vs 2Y Ago
9.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.62M | +186.8% |
| 2024 | $4.75M | +238.4% |
| 2023 | $1.40M | +592.3% |
| 2022 | $-285000.00 | - |